Metabolic remodeling precedes mTORC1-mediated cardiac hypertrophy

The nutrient sensing mechanistic target of rapamycin complex 1 (mTORC1) and its primary inhibitor, tuberin (TSC2), are cues for the development of cardiac hypertrophy. The phenotype of mTORC1 induced hypertrophy is unknown. To examine the impact of sustained mTORC1 activation on metabolism, function...

Full description

Saved in:
Bibliographic Details
Published inJournal of molecular and cellular cardiology Vol. 158; pp. 115 - 127
Main Authors Davogustto, Giovanni E., Salazar, Rebecca L., Vasquez, Hernan G., Karlstaedt, Anja, Dillon, William P., Guthrie, Patrick H., Martin, Joseph R., Vitrac, Heidi, De La Guardia, Gina, Vela, Deborah, Ribas-Latre, Aleix, Baumgartner, Corrine, Eckel-Mahan, Kristin, Taegtmeyer, Heinrich
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.09.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The nutrient sensing mechanistic target of rapamycin complex 1 (mTORC1) and its primary inhibitor, tuberin (TSC2), are cues for the development of cardiac hypertrophy. The phenotype of mTORC1 induced hypertrophy is unknown. To examine the impact of sustained mTORC1 activation on metabolism, function, and structure of the adult heart. We developed a mouse model of inducible, cardiac-specific sustained mTORC1 activation (mTORC1iSA) through deletion of Tsc2. Prior to hypertrophy, rates of glucose uptake and oxidation, as well as protein and enzymatic activity of glucose 6-phosphate isomerase (GPI) were decreased, while intracellular levels of glucose 6-phosphate (G6P) were increased. Subsequently, hypertrophy developed. Transcript levels of the fetal gene program and pathways of exercise-induced hypertrophy increased, while hypertrophy did not progress to heart failure. We therefore examined the hearts of wild-type mice subjected to voluntary physical activity and observed early changes in GPI, followed by hypertrophy. Rapamycin prevented these changes in both models. Activation of mTORC1 in the adult heart triggers the development of a non-specific form of hypertrophy which is preceded by changes in cardiac glucose metabolism. [Display omitted] •mTORC1 activation via inducible cardiac-specific TSC2 knockdown results in hypertrophy without contractile dysfunction.•mTORC1-induced cardiac hypertrophy is preceded by a decrease of glucose 6-phosphate isomerase levels and activity.•Activation of mTORC1 by voluntary exercise is associated with reduced TSC2 phosphorylation at Serine 1387.•In animals subjected to vuluntary exercise, changes in glucose 6-phosphate isomerase are present prior to hypertrophy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Current affiliation: Department of Cardiovascular Surgery, Baylor College of Medicine, Houston, TX, USA
Current affiliation: Department of Cardiology, Smidt Heart Institute, Department of Biomedical Sciences, Cedars Sinai Medical Center, CA, USA
Current affiliation: Center for Cell and Gene Therapy, Texas Children’s Hospital, Houston Methodist Hospital, and Baylor College of Medicine, Houston, TX, USA
Current affiliation: Edison Engineering Development Program, GE Healthcare, Chicago, IL, USA
Deceased
Current affiliation: Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
GD: designing research studies, conducting experiments, acquiring data, analyzing data, providing reagents, and writing the manuscript. RLS: conducting experiments, acquiring data, analyzing data, and writing the manuscript. HV: conducting experiments (perfusions, GPI assay, WB), revision of the manuscript. AK: conducting experiments (metabolite measurements), revision of the manuscript. WD: conducting experiments (qPCR), revision of the manuscript. PG: conducting experiments (perfusions). JM: conducting experiments (qPCR, perfusions), revision of the manuscript. BG: conducting experiments (WB, metabolite measurements), HVitrac: conducting experiments (Metabolite measurements), revision of the manuscript. GDLG: conducting experiments (qPCR, perfusions), revision of the manuscript. DV: conducting experiments (fibrosis assessment), revision of the manuscript. ARL: conducting experiments (voluntary exercise), revision of the manuscript. CB: conducting experiments (voluntary exercise), revision of the manuscript. KEM: assistance with experiment design (voluntary exercise), providing reagents (voluntary exercise wheels and infrared motion detectors), revision of the manuscript. HT: designing research studies, data analysis, providing reagents, and writing the manuscript.
Current affiliation: Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, Leipzig, Germany
Current affiliation: Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Author contributions
ISSN:0022-2828
1095-8584
DOI:10.1016/j.yjmcc.2021.05.016